#Digital Pathology Market
Link
#market research future#digital pathology market#digital pathology market size#digital pathology industry#digital pathology research
0 notes
Text
The Global Digital Pathology Market was valued at USD 1.4 Billion in 2023 and is estimated to reach USD 2.3 Billion by 2032, growing at a CAGR of 10.9 % from 2024 to 2033.
Digital Pathology includes the acquisition, sharing, and interpretation of pathologic information. It is the sub-field of pathology that focuses on data management based on information received from digitalized specimens. Digital pathology is mainly used by large biopharmaceuticals and top clinical research organizations to streamline drug development processes in discovery, clinical trials, and pre-clinical. The growth in digital pathology is boosted due to growing awareness of cancer diagnosis, growing applications of drug development, and precision medicines is propelling the market growth.
Emerging countries are expected to offer potential opportunities to the key players during the coming years.
To a certain extent, the market growth can be hampered due to increasing costs in the digital pathology systems.
Economic Impact of Covid-19:
The analysis of the COVID-19 recovery trajectory provides an overview of the main strategies that industries are implementing to respond to and recover from the economic crisis. It also focuses on the post-pandemic and pre-pandemic era of the Global Digital Pathology Market through PEST analysis, SWOT, Quantitative and Qualitative analysis, Attractive analysis, and DROs. Innovations by market players and an increasing number of products will propel the growth of this market.
Digital pathology hardware i.e. scanners are the major restraint in this market. The development of affordable scanners is expected to grow this market, as private medical practices can’t afford expensive digital pathology systems. Therefore, the invention of cost-effective scanners will allow small players to move towards the digitization of pathology workflow creating new opportunities in the digital pathology market.
Key Players:
Thermo Fisher Scientific Inc
Apollo Enterprise Imaging Group
Huron Technologies International Inc.
PROSCIA
GE Healthcare
Propath UK Limited
Roche Tissue Diagnostics & Visiopharm
Indica Labs
Akoya Biosciences
Ibex Medical Analytics
Sectra AB
Inspirata
Mikroscan Technologies
Olympus Corporation
Others
Know More- https://nexbindinsight.com/pharmaceutical-and-healthcare/the-global-digital-pathology-market-was-valued-at-usd-billion
0 notes
Text
Digital Pathology Market: Examined in New Market Research
A report has come out that gives an outline of the Digital Pathology Industry alongside a definite clarification that gives a lot of understanding. The meaning of the item/administration alongside the various utilizations of this item/administration in various end-client ventures can be tracked down in the outline. There is additionally a lot of data that features the development direction of the Digital Pathology Market. The data gives areas of strength for a to the market to be sectioned into various fragments. Truth be told, the data additionally shows the greatest portion of the overall industry during the estimate time frame by 2028.
Notwithstanding the abovementioned, the data depends on the accomplices that are exceptionally serious, vital participants as well as their market income in the conjecture long periods of 2022 to 2028. There is likewise areas of strength for an on item incomes, deals, item classes and, surprisingly, the items that are encountering the most footing. Thusly, the report likewise talks about the adequacy of the Ground Taking care of Administrations Market alongside its development during the conjecture time of 2030. Other significant characteristics of the market have been considered and broke down across numerous turns of events. This portrays a strong hold of the market for the impending time frame.
The central participants canvassed in this review
1. Koninklijke Philips N.V.
2. Nikon Corporation
3. Perkin Elmer, Inc.
4. Indica Labs
5. 3DHISTECH Ltd.
6. Hamamatsu Photonics K.K.
7. F. Hoffmann-La Roche Ltd
8. Visiopharm A/S
9. Glencoe Software, Inc.
10. Danaher Corporation
Division
The Digital Pathology Market has been fragmented based on various perspectives. The market is additionally divided by district. This division has been followed fully intent on separating bits of knowledge into the Ground Dealing with Administrations Market that are both nitty gritty as well as precise. The Advanced Pathology Market has been divided into Latin America, North America, Asia Pacific, Europe, and the Center East and Africa based on district
Research Philosophy
The report has its foundations most certainly set in exhaustive procedures given by the capable information experts. The exploration approach includes the assortment of data by examiners just to have them contemplated and separated completely trying to give huge expectations about the market over the audit period. The examination cycle further incorporates interviews with driving business sector powerhouses, which makes the essential exploration applicable and useful. The market techniques embraced in the report offer exact information examination and gives a visit through the whole market. Both essential and auxiliary ways to deal with information assortment have been utilized. What's more, freely accessible sources like SEC filings, yearly reports, and white papers have been utilized by information investigators for an adroit comprehension of the market. The exploration strategy plainly mirrors an aim to remove an exhaustive perspective available by having it broke down against numerous boundaries. The esteemed sources of info upgrade the report and proposition an edge over the friends.
Drivers and Requirements
The Digital Pathology Market rests joined with the rate of directing players who hold financing to the market's development essentially consistently. The report concentrates on the worth, volume patterns, and the valuing construction of the market so it could foresee most extreme development later on. Additionally, different stifled development variables, limitations, and potential open doors are likewise assessed for the high level review and ideas of the market over the evaluation period.
The Understanding Accomplice's devoted examination and investigation group comprise of experienced experts with cutting edge measurable mastery and proposition different customization choices in the current review.
Significant Highlights of Advanced Pathology Market Report:
• Save and diminish time completing section level exploration by recognizing the development, size, driving players and fragments in the Advanced Pathology market.
• Features key business needs to help organizations to realign their business systems.
• The vital discoveries and proposals feature significant moderate industry patterns in the Digital Pathology market, subsequently permitting players across the worth chain to foster powerful long-haul procedures.
Gratitude for perusing this article; you can likewise redo this report to get select parts or district wise inclusion with locales like Asia, North America, and Europe.
#Digital Pathology Market#Digital Pathology Market Size#Digital Pathology Market Trends#Digital Pathology Market Forecast#Digital Pathology Market Growth#Digital Pathology Market Analysis
0 notes
Text
Digital Pathology Market Is Estimated To Witness High Growth Owing To Increasing Adoption of Telepathology
The global Digital Pathology Market is estimated to be valued at US$ 884.4 million in 2023 and is expected to exhibit a CAGR of 12.2% over the forecast period, as highlighted in a new report published by Coherent Market Insights.
A) Market Overview:
Digital pathology is an advanced technology that involves the management, storage, and interpretation of pathology information in a digital format. It eliminates the need for physical slides and allows easy access to patient data for analysis and diagnosis. This technology offers numerous advantages such as enhanced accuracy, faster turnaround time, remote consultation, and improved collaboration among pathologists. The need for digital pathology solutions is driven by the rising demand for efficient diagnostic tools and the increasing complexity of pathological slides.
B) Market Key Trends:
One key trend in the global Digital Pathology market is the increasing adoption of telepathology. Telepathology allows pathologists to remotely access and interpret pathology images, enabling them to provide expert opinions and consultations regardless of geographical barriers. This trend has gained significant momentum due to the COVID-19 pandemic, which has increased the need for remote work and virtual healthcare solutions. Telepathology not only improves access to pathology expertise in underserved areas but also facilitates multi-disciplinary collaboration and enables faster diagnosis and treatment decisions.
C) PEST Analysis:
- Political: Regulatory policies and guidelines play a crucial role in the adoption of digital pathology solutions. Governments worldwide are focusing on enhancing healthcare infrastructure and promoting digitization in healthcare.
- Economic: The growing healthcare expenditure and increasing burden of chronic diseases are driving the demand for digital pathology solutions. Moreover, advancements in technology and cost reduction of digital pathology systems are also contributing to market growth.
- Social: The growing geriatric population, increasing prevalence of chronic diseases, and rising awareness about personalized medicine are factors driving the need for accurate and efficient diagnostic tools like digital pathology.
- Technological: Advancements in image analysis software, machine learning, and artificial intelligence have revolutionized digital pathology. These technologies enable automated analysis, better accuracy, and faster diagnosis, thereby boosting market growth.
D) Key Takeaways:
- The global Digital Pathology Market Demand is expected to witness high growth, exhibiting a CAGR of 12.2% over the forecast period, due to the increasing adoption of telepathology.
- North America is the fastest-growing and dominating region in the digital pathology market, attributed to the presence of well-established healthcare infrastructure, a high burden of chronic diseases, and a supportive regulatory environment.
- Key players operating in the global Digital Pathology Market include Leica Biosystems Nussloch GmbH, Olympus Corporation, F. Hoffmann-La Roche Ltd., Merck KGaA, GE Healthcare, Mikroscan Technologies, Inc., Koninklijke Philips N.V., Sectra AB, Propath UK Limited, Inspirata, Inc., Hamamatsu Photonics, Inc., OracleBio Limited, MD Biosciences, Aiforia, Xybion Digital Inc., and Nucleai, Inc.
In conclusion, the global Digital Pathology Market is experiencing significant growth due to the increasing adoption of telepathology and advancements in technology. This market has immense potential to improve diagnostic accuracy, enhance collaboration among pathologists, and facilitate remote consultations. As healthcare systems continue to embrace digitization, the demand for digital pathology solutions is expected to soar in the coming years.
#Digital Pathology#Digital Pathology Market#Digital Pathology Market Share#Digital Pathology Market Segments#Digital Pathology Market Size#Medical Devices
0 notes
Text
Digital Pathology Market Is Estimated To Witness High Growth Owing To Increased Adoption Of Digital Pathology Solutions And Rising Demand For Efficient Diagnostic Methods
A) Market Overview:
Digital pathology is a revolutionary technology that involves the capturing, managing, and interpreting of digital images from pathology slides. It eliminates the need for physical slides by digitizing them, allowing pathologists to view and analyze them using computer platforms. Digital pathology enables efficient storage, retrieval, and sharing of pathology images, making it a valuable tool in research, education, and diagnosis. The market offers various products such as scanners, software, and storage systems that enable the conversion of analog pathology slides to digital format
The global Digital Pathology Market is estimated to be valued at USD 884.4 million in 2023 and is expected to exhibit a CAGR of 12.2% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
B) Market Dynamics:
Increasing Adoption of Digital Pathology Solutions: The adoption of digital pathology solutions is steadily increasing, driven by the advantages they offer over traditional pathology methods. These solutions enable remote access, collaboration, and quick turnaround time for diagnosis, leading to improved patient outcomes. Additionally, digital pathology eliminates the risk of slide loss or damage and allows easy sharing of images for second opinions or consultation.
Rising Demand for Efficient Diagnostic Methods: The growing burden of diseases and the need for accurate and timely diagnoses are fueling the demand for efficient diagnostic methods like digital pathology. Digital pathology provides high-resolution images that allow pathologists to zoom in, annotate, and analyze tissue sections in detail. This enhances diagnostic accuracy and efficiency, leading to better patient management and treatment decisions.
C) Market Key Trends:
An emerging trend in the Digital Pathology Market Trends is the integration of artificial intelligence (AI) for image analysis and interpretation. AI algorithms can analyze large sets of pathology images, detect patterns, and provide automated diagnoses or assist pathologists in their diagnoses. This trend is revolutionizing the field of pathology, enabling more precise and faster diagnoses, especially in complex cases. For example, AI algorithms can identify cancerous cells, predict disease progression, and provide personalized treatment recommendations.
D) SWOT Analysis:
Strengths:
Efficient and accurate diagnosis
Improved collaboration and remote access
Weaknesses:
High upfront costs of digital pathology solutions
Limited adoption in developing regions due to infrastructure limitation
Opportunities:
Integration of AI for advanced image analysis
Expansion of digital pathology in telepathology and research applications
Threats:
Data security and privacy concerns
Resistance from traditional pathologists to switch to digital methods
E) Key Takeaways:
- The global digital pathology market is expected to witness high growth, exhibiting a CAGR of 12.2% over the forecast period, due to the increasing adoption of digital pathology solutions and the rising demand for efficient diagnostic methods.
- North America is anticipated to be the fastest-growing and dominating region in the digital pathology market, driven by advanced healthcare infrastructure, favorable reimbursement policies, and the presence of key market players.
- Key players operating in the global digital pathology market include Leica Biosystems Nussloch GmbH, Olympus Corporation, F. Hoffmann-La Roche Ltd., Merck KGaA, GE Healthcare, Mikroscan Technologies, Inc., Koninklijke Philips N.V., Sectra AB, Propath UK Limited, Inspirata, Inc., Hamamatsu Photonics, Inc., OracleBio Limited, MD Biosciences, Aiforia, Xybion Digital Inc., and Nucleai, Inc.
In conclusion, the digital pathology market is experiencing significant growth due to the increasing adoption of digital pathology solutions and the rising demand for more efficient diagnostic methods. The integration of AI in digital pathology and the expansion of its applications present exciting opportunities for market growth. However, challenges such as high upfront costs and data security concerns need to be addressed for widespread adoption. Overall, digital pathology has the potential to transform pathology practices and improve patient outcomes.
#Digital Pathology Market#Digital Pathology Market Demand#Digital Pathology Market Sale#Digital Pathology Market trends#Digital Pathology Market Growth#Digital Pathology Market Analysis#Coherent Market Insights
0 notes
Text
Next-Gen Digital Pathology Conference 2023: Bridging Pharma and Cutting-Edge Pathology Innovations
In the rapidly evolving landscape of healthcare, the integration of technology has paved the way for remarkable advancements. One such groundbreaking transformation is the intersection of pharmaceuticals and digital pathology. The amalgamation of these two fields has not only streamlined diagnostics but also revolutionized drug development and patient care. This blog delves into the multifaceted role of pharmaceutical companies in digital pathology, highlighting upcoming innovations, compelling case studies, and cutting-edge research.
THE INTERSECTION OF PHARMA AND DIGITAL PATHOLOGY: A SYNERGISTIC PARTNERSHIP
Digital pathology involves the digitization of pathology slides, allowing for easier storage, analysis, and sharing of images. In this era of big data and artificial intelligence (AI), pharmaceutical companies have found themselves at the forefront of leveraging digital pathology for a multitude of purposes.
1. Drug Discovery and Development: Pharmaceutical companies are utilizing digital pathology to accelerate the drug discovery process. With the help of AI algorithms, they can analyze tissue samples more efficiently, identifying potential drug targets and biomarkers. This approach expedites preclinical and clinical studies, ultimately shortening the time it takes for new drugs to reach patients.
2. Personalized Medicine: The advent of digital pathology has paved the way for personalized medicine. By analyzing individual patient data, pharmaceutical companies can tailor treatments based on a patient's unique genetic and molecular profile. This precision approach not only enhances treatment efficacy but also minimizes adverse effects.
3. Clinical Trials: Digital pathology aids in streamlining clinical trials by facilitating remote collaboration among researchers and experts. Pathological assessments can be conducted more effectively, ensuring accurate data interpretation, and reducing trial timelines.UPCOMING INNOVATIONS IN PHARMA AND DIGITAL PATHOLOGY
The marriage of pharmaceuticals and digital pathology continues to evolve, with several exciting innovations on the horizon:
1. AI-Powered Diagnostics: Advanced AI algorithms are being developed to assist pathologists in diagnosing diseases more accurately and rapidly. These algorithms can analyze vast amounts of data, aiding pathologists in making informed decisions.
2. Virtual Tumour Boards: Pharma companies are exploring virtual tumour boards where pathologists, oncologists, and other experts can collaborate in real-time, leading to more comprehensive treatment strategies.
3. Telepathology Solutions: Remote consultation and diagnosis through telepathology are becoming increasingly feasible, allowing experts to offer their insights regardless of geographical constraints.CASE STUDIES AND RESEARCH BREAKTHROUGHS
Several case studies highlight the successful integration of pharma and digital pathology:
1. Merck's Cancer Biomarker Discovery: Merck utilized digital pathology to identify potential cancer biomarkers, accelerating their drug development pipeline.
2. Novartis' Precision Medicine: Novartis leveraged digital pathology to identify patient subgroups likely to respond to a certain drug, ensuring a more personalized approach to treatment.
3. Pfizer's Drug Safety Assessment: Pfizer employed digital pathology to enhance the assessment of drug safety, improving decision-making in the drug development process.MARKET INSIGHTS AND THE NEXT-GEN DIGITAL PATHOLOGY CONFERENCE
The connection between the blog topic and the forthcoming MarketsandMarkets Next-Gen Digital Pathology Conference, scheduled for October 19th-20th, 2023, in Boston, USA, is evident. This conference serves as a platform for industry leaders, researchers, and experts to converge and share insights about the latest developments in digital pathology and its interface with pharmaceuticals.
The early bird discount of 20% with code DGPB20, expiring on August 31st, 2023, presents a valuable opportunity for participants to engage with pioneering minds, explore innovations, and gain a comprehensive understanding of the dynamic landscape of pharma and digital pathology.
Conclusion
The symbiotic relationship between pharmaceuticals and digital pathology has ushered in a new era of healthcare. As pharmaceutical companies continue to leverage digital pathology for drug discovery, personalized medicine, and clinical trials, the impact on patient care and treatment outcomes is immeasurable. The upcoming MarketsandMarkets Next-Gen Digital Pathology Conference is a prime platform to stay updated on these transformative developments, offering a chance to be part of the cutting-edge dialogue that shapes the future of healthcare.
Seize the opportunity and register now to avail the early bird discount before it expires on August 31st, 2023.
0 notes
Text
Global Digital Pathology Market Size, Share and Suppliers to 2031
The global digital pathology market size was valued at USD 986.24 million in 2022. It is projected to reach USD 1843.89 million by 2031, growing with a CAGR of 7.2% during the forecast period (2023–2031).
#Digital Pathology Market#Digital Pathology Market Share#Digital Pathology Industry#Digital Pathology Market Size#Digital Pathology Market Research#What is Digital Pathology?#Digital Pathology Market Drivers#North America Digital Pathology Market#Europe Digital Pathology Market#Asia Pacific Digital Pathology Market#LAMEA Digital Pathology Market#Global Digital Pathology Market
0 notes
Text
Digital Pathology Market – Growth, Trends & Forecast 2030
Growth of the global digital pathology market is majorly driven by the increase in the prevalence of cancer; a rise in the demand for accurate diagnostics, and the development of new digital pathology systems by a large number of key players. According to a report published by Medscape, chronic diseases can be associated with a higher mortality rate. The fundamental cause for the development of advanced diagnostic solutions is the rise prevalence of cardiovascular disorders. Thus, as the prevalence of chronic and cardiovascular diseases rises, the need for digital pathology systems increases driving the growth of the digital pathology market.
The global Digital Pathology Market size is 799.296 million USD in 2022 and is projected to reach a CAGR of 8.6% from 2023-2030.
On the other hand, the high cost of a typical digital pathology system, coupled with the lack of skilled personnel to operate them is expected to limit the adoption of these systems. The cost, which includes a slide scanner, an image server, and software, costs around USD 500,000 to USD 700,000. While in the Asia Pacific, the average price is around USD 110,000 to USD 130,000. Although large hospitals with significant capital budgets can afford these systems, pathologists and academic institutes with limited budgets or IT support often cannot afford them, this significantly restricts the Digital Pathology Market.
To Understand Business Strategies, Request for a Sample Report at: https://www.delvens.com/get-free-sample/digital-pathology-market-trends-forecast-till-2030
Delvens Industry Expert's Standpoint
Due to its ability to ascertain and comprehend the causes of diseases, digital diagnosis plays a significant role in the diagnosis of many chronic diseases. The efficiency, effectiveness, and safety of disease diagnosis in pathology laboratories are improved by the integration of digital pathology with digital tools like barcoding, specimen tracking, digital dictation, and others. Multiple pathologists can instantly share entire slides through a digital pathology platform to contribute to a case at once. The rise in the incidence of cancer, the requirement for precise diagnoses, and the creation of innovative digital pathology systems are the primary factors driving the worldwide market for digital pathology.
Regional Analysis:
North America accounted for the largest share of the digital pathology market during the forecast period. The increasing prevalence of cancer, rising demand for quality diagnostics, the introduction of favorable reimbursement policies, and the implementation of favorable initiatives by the governments in the US and Canada are major factors driving the growth of the digital pathology market in North America.
To Grow Your Business Revenue, Make an Inquiry Before Buying at: https://www.delvens.com/Inquire-before-buying/digital-pathology-market-trends-forecast-till-2030
Key Findings
The scanners segment is further segmented into Scanners, Software, and Storage systems. The scanners segment is expected to hold the highest orientation during the forecast period. The large share of the scanners segment can be attributed to the high price of scanners and the increasing adoption of digital pathology solutions.
The type segment is further segmented into Human Pathology and Veterinary Pathology. The human pathology segment is anticipated to hold the largest share during the forecast period. This is due to the increasing number of cancer research activities and growing collaborations among research institutes, universities, and pathology laboratories.
The application segment is further fragmented into Drug Discovery, Disease Diagnosis, and Training & Education. The drug discovery segment is expected to reach the highest CAGR during the forecast period. Growth in R&D expenditure fuelled by the need for numerous preclinical and clinical studies performed during the drug discovery and development process is a major factor responsible for market growth.
The end-user segment is further segmented into Pharmaceutical & Biotechnology Companies, Hospitals and Reference Laboratories, and Academic & Research Institutes. The segment is expected to hold the largest share in Pharmaceutical & Biotechnology Companies. The large share of this segment can be attributed to the increasing use of digital pathology for drug discovery studies and drug toxicology testing. Biotechnology companies also use digital pathology for biobanking, biopharmaceutical studies, molecular assays, and the development of individualized medicine.
Direct Purchase of Digital Pathology Market Report at: https://www.delvens.com/checkout/digital-pathology-market-trends-forecast-till-2030
According to the research done the top players of Digital Pathology market are:
3DHISTECH LTD, Danaher Corporation, Glencoe Software Inc., HAMAMATSU Photonics K.K, Indica Labs Inc., Koninklijke Philips N.V, Nikon Corporation, Perkinelmer Inc., Roche, and VisoPharma A/S are the major players operating in Digital Pathology Market.
Recent Developments in the Digital Pathology Market:
In September 2021, Visiopharm (Denmark) and Agilent Technologies, Inc. (US) collaborated to co-market Visiopharm’s portfolio of CE-IVD marked AI-driven Precision Pathology software and Agilent’s automated pathology staining solutions portfolio.
In August 2021, Sectra AB (Sweden) and University Medical Center Utrecht (Netherlands) signed an agreement under which UMC uses Sectra’s pathology module for effective multidisciplinary discussions among pathologists and radiologists.
Reasons to Acquire this trending report of Digital Pathology Market:
Increase your understanding of the market for identifying the best and most suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends, and factors
Gain authentic and granular data access for Digital Pathology Market so as to understand the trends and the factors involved in changing market situations
Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns
Read related Healthcare Reports:
2030 Forecast: Fitness Equipment Market https://www.delvens.com/report/fitness-equipment-market-trends-forecast-till-2030
Dermatology Device Market https://www.delvens.com/report/dermatology-devices-market-trends-forecast-till-2030
Robot Assisted Surgery Market https://www.delvens.com/report/robot-assisted-surgery-market-trends-forecast-till-2030
Explore: Who We Are..
Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.
Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.
Contact Us:
UNIT NO. 2126, TOWER B,
21ST FLOOR ALPHATHUM
SECTOR 90 NOIDA 201305, IN
+44-20-8638-5055
#consulting company#strategic advisory firm#digital pathology market#digital pathology market size#digital pathology analysis report#syndicated reports#best market reports#market analysis reports
0 notes
Text
Digital Pathology Market 2023-2030 Expected Developments to be observed worldwide
Digital pathology is the practice of using digital technology to create, manage, and interpret digital images of tissue samples for diagnostic, educational, and research purposes. It involves the acquisition, processing, and analysis of digital images of pathology specimens, which are then viewed and interpreted by pathologists using computers.
Some key aspects of digital pathology include:
For Download Sample Report Click Here: https://www.globmarketreports.com/request-sample/234012
Digital slide scanning: Pathology slides are digitized using high-resolution scanners to create high-quality, digital images that can be viewed and analyzed on a computer.
Image management: Digital pathology systems include software for managing and organizing digital images, including storage, retrieval, and archiving.
Image analysis: Digital pathology allows for advanced image analysis techniques, such as computer-aided diagnosis and automated image recognition, to aid in the interpretation of images.
Telepathology: Digital pathology enables remote consultation and collaboration between pathologists, allowing for improved access to pathology expertise and faster turnaround times for diagnoses.
Digital pathology has several advantages over traditional pathology methods, including:
Improved accuracy and precision: Digital pathology allows for more precise and accurate measurements and analysis of pathology specimens.
Increased efficiency: Digital pathology enables faster and more efficient slide scanning and image analysis, leading to faster turnaround times for diagnoses.
Enhanced collaboration and education: Digital pathology enables remote consultation and collaboration between pathologists, as well as improved access to pathology expertise for medical education and training.
Improved patient care: Digital pathology allows for more accurate and timely diagnoses, leading to improved patient outcomes.
Overall, digital pathology is a rapidly evolving field that has the potential to transform the practice of pathology, improving accuracy, efficiency, and patient care.
0 notes
Link
#market research future#digital pathology market#digital pathology market 2018#digital pathology market size#digital pathology market trend
0 notes
Text
Digital pathology Market Overview, Size, Share Analysis, Key Companies, and Forecast To 2028
0 notes
Text
The Global Digital Pathology Market Continues To Grow Owing To the Recent Developments Done By Central Market Players in the World
Market Overview:
Digital pathology also offers more options for viewing, marking, and sharing images. It makes it easier for pathologists to search for cases with similar features, share slides with colleagues, and build predictive models. Using cloud storage means pathologists from around the world can access images and collaborate with one another. Using digital slides can also improve patient care. The benefits of digital pathology go beyond the ability to distribute digital slides. Digital images can be used for specialized analytics, some of which incorporate artificial intelligence. There are some downsides to digital pathology, however. It is important to weigh the benefits of digital pathology with its drawbacks. It may cause some delays in the workflow, but the benefits outweigh the disadvantages.
Competitive Landscape:
Major players operating in the global digital pathology market include Paige, Motic, Mikroscan Technologies, Kanteron Systems, Proscia Inc., PathAI, Inspirata, Inc., KONFOONG BIOTECH INTERNATIONAL CO., LTD., Glencoe Software, OptraSCAN, Sectra AB, Objective Pathology Services, Indica Labs, Corista, Akoya Biosciences, Aiforia Technologies Oy, Visiopharm A/S, Huron Digital Pathology, XIFIN, Inc., Apollo Enterprise Imaging, 3DHISTECH, F. Hoffmann-La Roche Ltd., Hamamatsu Photonics, Koninklijke Philips N.V., and Leica Biosystems.
Key Market Drivers:
Increasing developments related to the global digital pathology market are expected to augment the growth of the market, For instance, in September 2021, Visiopharm and Agilent Technologies, Inc. partnered in order to co-market Visiopharm’s CE-IVD marked Artificial Intelligence-driven Precision Pathology software, along with the automated pathology staining solutions of Agilent. Although digital pathology has only just begun to enter the clinical world, it already offers many benefits. Digital pathology tools can help pathologists make faster, more accurate diagnoses. They can also share results with other experts, and they can be shared in educational settings. The increasing expansion of pathology labs in the world is estimated to enhance the growth of the global digital pathology market.
Covid-19 Impact Analysis:
During the COVID-19 pandemic, there have been several developments in the global digital pathology market. For instance, in April 2021, Paige.AI, Inc. and Leica Biosystems collaborated on Paige’s AI-enabled research software to aid in grading and tumor detection.
Key Takeaways:
· North America is expected to dominate the growth of the global digital pathology market, owing to the recent developments by key players in the region. For instance, in August 2020, Bio-Techne Corporation and Leica Biosystems collaborated in order to automate RNAscope COVID-19 probes on Leica’s BOND RX platform for research purposes.
· Europe is estimated to witness high growth in the global digital pathology market, owing to the high expansion of key market players in the region. For instance, in August 2021, University Medical Center Utrecht and Sectra AB signed went in a partnership, in order to use Sectra’s pathology module.
0 notes
Last Seen Blogs
kisaragisora2128
kisaragi-sora
rislata
Stiles
luxuryavenueinteriors
Luxury Avenue Interiors
sze-ret-lek
.sehogysejo.
vukuu
vukuu